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Purpose: An ultraviolet spectrophotometric system was developed and validated for the quantitative 
determination of lornoxicam in solid dosage forms. 
Methods:  Lornoxicam was dissolved in 0.01M NaOH and analysed using ultraviolet (UV) 
spectrophotometry. Various analytical parameters such as linearity, precision, accuracy, limit of 
detection (LOD) and limit of quantification (LOQ) were determined according to International Conference 
on Harmonization (ICH) guidelines.  
Results: Absorbance maximum in 0.01M NaOH was 377 nm. Beer’s law was obeyed over the 
concentration range of 2 - 20 µg/ml with a correlation coefficient (r2) value of 0.999. Percent range of 
error was 0.344 and 0.261 at 0.05 and. 0.01 confidence limits, respectively. Intra- and inter-day 
precision (% RSD) at different concentration levels were < 2 %, indicating that the proposed derivative 
spectrophotometric method is highly reproducible during one run and between different runs; LOD and 
LOQ were 0.105 and 0.318 µg/ml, respectively signifying that it can be adopted  for  routine quality 
testing. Mean recovery was 100.82 % for tablets. Low values of % RSD indicate the reliability of the 
proposed method 
Conclusion: The proposed method is highly sensitive, precise, accurate, cost-effective, reliable and 
rapid for the estimation of lornoxicam in solid dosage forms. 
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carboxamide-1,1-dioxide) a non-steroidal 
anti-inflammatory drug (NSAID) with potent 
analgesic and anti-inflammatory activity. It 
belongs to the class of oxicams and is 
approximately ten times more potent than 
oxicams such as piroxicam and tenoxicam 
[1]. It is used for the treatment of rheumatoid 
arthritis and other rheumatic diseases and is 
available in the market as tablet and injection.  
  
A literature survey showed that the analysis 
of lornoxicam in pharmaceutical preparations 
is usually by high performance liquid 
chromatography (HPLC), voltammetry as well 
as zero- and first-order derivative UV 
spectrophotometric methods [2],. However, to 
the best of our knowledge, no method has 
been established and validated by linear 
regression equation method which is a 
promising straightforward method that has 
gained extensive recognition. 
 
The objective of the present study was to 
develop a simple, precise and reliable 
spectrophotometric method, using 0.01M 
NaOH as solvent, as a rapid, direct and cost-
effective alternative to the determination of 






A commercial brand of lornoxicam tablet, 
Zion®, (,8 mg lornoxicam, Unichem, India) 
was obtained from a local pharmacy. 
Lornoxicam powder (purity, 99.9 %), received 
gratis from Hetero Drugs, Hyderabad, India, 
was used as such without further purification. 
All other chemicals used were of analytical 
grade. All the solutions for analysis were 
freshly prepared and analyzed. 
Spectrophotometric analysis was performed 
with Systronic 2101 and Elico SL 159 UV–Vis 
spectrophotometer. Addir Dutt electronic 
balance (AD-50B, Kolkata, India) was used 
for the assessment of tablet weight variation.  
 
Preparation of working standard solutions 
 
A working standard solution of lornoxicam 
was prepared by dissolving 50 mg of the 
standard (pure) lornoxicam in an appropriate 
volume of 0.01M NaOH to obtain a solution of 
100 µg/ml concentration. Aliquots (1 - 10 ml) 
of the working standard solution were 
transferred into a series of 50 ml volumetric 
flasks to obtain final drug concentrations of 2 
- 20 µg/ml.  
 
Analysis of the drug and validation of the 
proposed method 
 
Twenty tablets of lornoxicam were crushed in 
a mortar and pestle to a fine powder and an 
amount equivalent to 8 mg (accurately 
weighed) was extracted at room temperature 
in a shaker with 100 ml 0.01M NaOH for 45 
min. The mixture was filtered through 
Whatman filter paper no. 1. and suitably 
diluted with 0.01M NaOH to obtain a 
concentration of 10 µg/ml of lornoxicam [3]. 
The absorbance of these solutions was 
determined at 377 nm against a reagent 
blank (0.01M NaOH solution). The 
repeatability of the method was established 
by carrying out analysis (n = 8) of the analyte 




The accuracy of the developed assay method 
was evaluated by evaluating the recovery of 
lornoxicam by standard addition method at 
concentrations of 80, 100 and 120 % of the 
target level in tablets [5]. The percent 
analytical recovery was calculated by 
comparing the concentration obtained from 
spiked samples with actual added 
concentration and the values are listed in 
Table 1. 
 
The precision of the method was 
demonstrated by inter-day and intra-day 
variation studies using three different concen- 
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pure drug taken 
(µg/ml) 
Concentration of tablet 
formulation 
(µg/ml) 




C : 80% 8 10 99.91 ± 0.830 0.831 
C : 100% 10 10 100.38  ± 0.880 0.877 
C : 120% 12 10 102.18  ±  0.322 0.316 
Note: RSD = relative standard deviation 
 
        Table 2: Precision data (n = 3) 
 
Inter-day Intra-day Amount taken 
(µg/ml) Content (µg/ml) % RSD Content (µg/ml) % RSD 
8 7.940 ± 0.054 0.690 7.98± 0.013 0.168 
10 9.940 ± 0.077 0.775 9.98 ± 0.014 0.134 
12 11.960 ± 0.044 0.372 11.97 ± 0.026 0.225 
       Note: RSD = relative standard deviation 
 
trations of drug (in addition to calibration 
standards) covering the entire linearity range 
[6]. In intra-day studies, the drug was 
analyzed on the same day while inter-day 
precision was determined by analyzing the 
drug for three consecutive days. The results 
are presented as standard deviation and % 




The reliability of the proposed method was 
determined at 12 µg/ml by using different 
instruments that is by Systronic 2101 and 
Elico SL 159 UV–Vis spectrophotometer 
under similar setting [7]. 
 
Limits of detection (LOD) and quantification 
(LOQ) 
 
LOD and LOQ were calculated as 3.3 σ/S 
and 10 σ/S, respectively, where σ is the 
standard deviation of the standard 
concentration and S is the slope of the 
standard curve. The limit of detection (LOD) 
is the lowest concentration of an analyte that 
an analytical process can reliably differentiate 
from background levels. The limit of 
quantification (LOQ) is the lowest 
concentration of the standard curve that can 
be measured with acceptable accuracy, 
precision and variability [8].  
Statistical analysis 
 
The data obtained were expressed as mean 
± standard deviation (SD), and statistical 
analysis of the data was performed using 
one-way ANOVA (Graph Pad Prism software, 
version 5). Differences between formulations 




The optical  characteristics were as follows: 
Beer's law limit, 2 to 20 µg/ml; absorbance 
maximum, 377 nm; molar absorptivity, 
465.065 L M-l cm-I; Sandell's sensitivity, 0.023 
µg cm-I/0.001 absorbance unit; correlation 
coefficient (r2), > 0.999; regression equation, 
y =0.043X + 0.016; slope, 0.043; intercept, 
0.016; % RSD, 0.834; and % range of error, 
0.344 and 0.261 at 0.05 and 0.01 confidence 
limits, respectively. Molar absorptivity and 
Sandell’s sensitivity data show that the 
method is perceptive. The assay value for the 
commercially marketed tablet was 99.91 % 
with a % R.S.D. 0.831. 
 
Mean recovery was 100.82% for the tablets 
by the proposed method while LOD and LOQ 
were 0.105 and 0.318 µg/ml, respectively.  
The intra- and inter-day precision (% RSD) at 
different concentration levels were < 2 % 
(Table 2), indicating that the proposed 
derivative spectrophotometric method is 
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(µg/ml) % RSD 
Systronics-2101 12 11.98±0.01 0.083 
Elico SL-159 12 11.95±0.02 0.174 
        Note: RSD = relative standard deviation 
 
highly reproducible during one run and 
between different runs [9]. Low values of % 
RSD for reliability studies (Table 3) at p ≤ 
0.05 indicate that there was no statistically 
significant difference between the two 
different UV spectrophotometric instruments 




The present study is an attempt to develop a 
simple, accurate and sensitive UV 
spectrophotometric method for the 
determination of lornoxicam in solid dosage 
forms, specifically tablets. The linearity of 
lornoxicam solution in the concentration 
range 2 to 20 µg/ml was satisfactory with 
absorbance maximum at 377 nm. The low 
values of standard error established the 
precision of the proposed method. The low 
values of LOQ and LOD of the proposed 
method signify that it can be adopted  for  
routine quality testing and dissolution studies. 
Sample recovery for tablets was in good 
agreement with its label claim. The within–
day and between-day precision (% RSD ) 
were satisfactory  and established the 
repeatability and reproducibility of the 




The proposed UV method for the analysis of 
lornoxicam is simple, fast and reliable, 
providing satisfactory accuracy and precision. 
Moreover, the short duration of analysis of 
lornoxicam make the developed method 
suitable for the routine quantitative analysis 
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